Immunovant Inc (IMVT)
30.30
-0.57
(-1.85%)
USD |
NASDAQ |
May 21, 11:39
Immunovant Total Assets (Quarterly): 711.45M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 711.45M |
September 30, 2023 | 292.07M |
June 30, 2023 | 351.22M |
March 31, 2023 | 405.84M |
December 31, 2022 | 456.24M |
September 30, 2022 | 428.15M |
June 30, 2022 | 458.66M |
March 31, 2022 | 515.56M |
December 31, 2021 | 543.18M |
September 30, 2021 | 566.73M |
Date | Value |
---|---|
June 30, 2021 | 388.03M |
March 31, 2021 | 412.49M |
December 31, 2020 | 433.03M |
September 30, 2020 | 453.90M |
June 30, 2020 | 290.29M |
March 31, 2020 | 109.39M |
December 31, 2019 | 126.62M |
September 30, 2019 | 117.79M |
June 30, 2019 | 117.42M |
March 31, 2019 | 0.3246M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
109.39M
Minimum
Mar 2020
711.45M
Maximum
Dec 2023
377.79M
Average
412.49M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
Perspective Therapeutics Inc | 278.29M |
Electromed Inc | 48.90M |
Xtant Medical Holdings Inc | 93.93M |
Asensus Surgical Inc | 40.81M |
Myomo Inc | 16.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 32.10M |
Shareholders Equity (Quarterly) | 679.34M |